Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin Once vs Thrice a Day in Septic Abortion
NCT02309346Phase 4Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Dec 2014
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of clindamycin in septic abortion (2 arms), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoint: Percentage of Participants Cured at 7 days. Started Dec 2014; status: completed.
02
Drugs
clindamycin
03
Conditions
septic abortion
Beyond the preview
Go deeper on NCT02309346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02309346.